Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Dimethyl fumarate 120mg gastro-resistant tablets
0802040AKAAADAD
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | 8 |
|
Imatinib 100mg tablets
0801050AAAAACAC
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 8 |
|
Orgovyx 120mg tablets
0803042X0BBAAAA
|
Orgovyx | Relugolix | Malignant Disease and Immunosuppression | 8 |
|
Sandimmun 25mg capsules
0802020G0BBADAC
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 8 |
|
Sandostatin 500micrograms/1ml inj ampoules
0803043N0BBACAC
|
Sandostatin | Octreotide acetate | Malignant Disease and Immunosuppression | 7 |
|
Azapress 50mg tablets
0802010G0BHAAAE
|
Azapress | Azathioprine | Malignant Disease and Immunosuppression | 6 |
|
Azathioprine 25mg/5ml oral solution
0802010G0AAASAS
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 6 |
|
Dimethyl fumarate 30mg gastro-resistant tablets
0802040AKAAACAC
|
Dimethyl fumar | Dimethyl fumar | Malignant Disease and Immunosuppression | 6 |
|
Ruxolitinib 5mg tablets
0801050BIAAAAAA
|
Ruxolitinib | Ruxolitinib | Malignant Disease and Immunosuppression | 6 |
|
Sandimmun 100mg capsules
0802020G0BBAEAD
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 6 |
|
Dailiport 3mg modified-release capsules
0802020T0BKACAT
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 5 |
|
Lutrate 1 month Depot 3.75mg inj vials
0803042N0BCAAAA
|
Lutrate | Leuprorelin acetate | Malignant Disease and Immunosuppression | 5 |
|
Buserelin 100micrograms/dose nasal spray
0803042B0AAABAB
|
Buserelin (Prostate) | Buserelin | Malignant Disease and Immunosuppression | 4 |
|
Dailiport 2mg modified-release capsules
0802020T0BKAEBJ
|
Dailiport | Tacrolimus | Malignant Disease and Immunosuppression | 4 |
|
Everolimus 5mg tablets
0801050AXAAAAAA
|
Everolimus | Everolimus | Malignant Disease and Immunosuppression | 4 |
|
Olatuton 20mg inj vials
0803043N0BCABAG
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | 4 |
|
Olatuton 30mg inj vials
0803043N0BCACAF
|
Olatuton | Octreotide acetate | Malignant Disease and Immunosuppression | 4 |
|
Rapamune 1mg/ml oral solution
0802020U0BBACAC
|
Rapamune | Sirolimus | Malignant Disease and Immunosuppression | 4 |
|
Tacrolimus 1mg modified-release tablets
0802020T0AABCBC
|
Tacrolimus (Systemic) | Tacrolimus | Malignant Disease and Immunosuppression | 4 |
|
Thalidomide 50mg capsules
0802040AAAAAAAA
|
Thalidomide (Immunomodulating) | Thalidomide (Immunomodulating) | Malignant Disease and Immunosuppression | 4 |
|
Vanquoral 10mg capsules
0802020G0BHADAH
|
Vanquoral | Ciclosporin | Malignant Disease and Immunosuppression | 4 |
|
Azathioprine 250mg/5ml oral liquid
0802010G0AACGCG
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 3 |
|
Busulfan 2mg tablets
0801010B0AAABAB
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | 3 |
|
Fingolimod 500microgram capsules
0802040ADAAAAAA
|
Fingolimod hydrochloride | Fingolimod | Malignant Disease and Immunosuppression | 3 |
|
Imatinib 100mg capsules
0801050AAAAAAAA
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 3 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.